125-65-5,MFCD28154633
Catalog No.:AA00HHSO

125-65-5 | Pleuromulin

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
98%(HPLC)
in stock  
$24.00   $17.00
- +
25mg
98%(HPLC)
in stock  
$61.00   $43.00
- +
100mg
98%(HPLC)
in stock  
$178.00   $125.00
- +
250mg
95%
in stock  
$341.00   $239.00
- +
1g
98%(HPLC)
in stock  
$556.00   $389.00
- +
5g
98%(HPLC)
in stock  
$1,223.00   $856.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00HHSO
Chemical Name:
Pleuromulin
CAS Number:
125-65-5
Molecular Formula:
C22H34O5
Molecular Weight:
378.5024
MDL Number:
MFCD28154633
SMILES:
OCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@@H](C23[C@H](C1(C)[C@H](C)CC2)C(=O)CC3)C
Properties
Computed Properties
 
Complexity:
645  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
6  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
2  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.5  

Literature

Title: Novel pleuromutilin derivatives as antibacterial agents: synthesis, biological evaluation and molecular docking studies.

Journal: Bioorganic & medicinal chemistry letters 20121001

Title: Design, synthesis, and antibacterial activity of novel pleuromutilin derivatives bearing an amino thiazolyl ring.

Journal: Archiv der Pharmazie 20120801

Title: Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs).

Journal: The Journal of antimicrobial chemotherapy 20120501

Title: A click chemistry approach to pleuromutilin derivatives, part 2: conjugates with acyclic nucleosides and their ribosomal binding and antibacterial activity.

Journal: Journal of medicinal chemistry 20120308

Title: Pleuromutilin and its derivatives-the lead compounds for novel antibiotics.

Journal: Mini reviews in medicinal chemistry 20120101

Title: Are pleuromutilin antibiotics finally fit for human use?

Journal: Annals of the New York Academy of Sciences 20111201

Title: A stereoselective, Sm(II)-mediated approach to decorated cis-hydrindanes: synthetic studies on faurinone and pleuromutilin.

Journal: Organic & biomolecular chemistry 20110407

Title: A concise synthesis of the molecular framework of pleuromutilin.

Journal: Chemical communications (Cambridge, England) 20110207

Title: Small plasmids carrying vga(A) or vga(C) genes mediate resistance to lincosamides, pleuromutilins and streptogramin A antibiotics in methicillin-resistant Staphylococcus aureus ST398 from swine.

Journal: The Journal of antimicrobial chemotherapy 20101201

Title: The pleuromutilin antibiotics: a new class for human use.

Journal: Current opinion in investigational drugs (London, England : 2000) 20100201

Title: Characterization of pACK4, a mobilizable plasmid from Staphylococcus simulans biovar staphylolyticus.

Journal: Plasmid 20091101

Title: Mutilins derivatives: from veterinary to human-used antibiotics.

Journal: Mini reviews in medicinal chemistry 20091001

Title: Water-soluble phosphate prodrugs of pleuromutilin analogues with potent in vivo antibacterial activity against Gram-positive pathogens.

Journal: Bioorganic & medicinal chemistry letters 20090915

Title: Investigating pleuromutilin-producing Clitopilus species and related basidiomycetes.

Journal: FEMS microbiology letters 20090801

Title: Novel pleuromutilin derivatives with excellent antibacterial activity against Staphylococcus aureus.

Journal: Chemical biology & drug design 20090601

Title: Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics in Mycobacterium smegmatis by perturbation of the drug binding pocket.

Journal: Molecular microbiology 20090301

Title: A scalable synthesis of 2S-hydroxymutilin via a modified Rubottom oxidation.

Journal: The Journal of organic chemistry 20090102

Title: Pleuromutilin derivatives having a purine ring. Part 3: synthesis and antibacterial activity of novel compounds possessing a piperazine ring spacer.

Journal: Bioorganic & medicinal chemistry letters 20090101

Title: Pleuromutilin derivatives having a purine ring. Part 2: influence of the central spacer on the antibacterial activity against Gram-positive pathogens.

Journal: Bioorganic & medicinal chemistry letters 20090101

Title: A dialdehyde cyclization cascade: an approach to pleuromutilin.

Journal: Angewandte Chemie (International ed. in English) 20090101

Title: A click chemistry approach to pleuromutilin conjugates with nucleosides or acyclic nucleoside derivatives and their binding to the bacterial ribosome.

Journal: Journal of medicinal chemistry 20080828

Title: Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens.

Journal: Bioorganic & medicinal chemistry letters 20080615

Title: Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.

Journal: Journal of medicinal chemistry 20080410

Title: Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.

Journal: Future microbiology 20071201

Title: Studies on the later stage of the biosynthesis of pleuromutilin.

Journal: Bioscience, biotechnology, and biochemistry 20071201

Title: Cyclopentanone ring-cleaved pleuromutilin derivatives.

Journal: European journal of medicinal chemistry 20070101

Title: Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci.

Journal: Antimicrobial agents and chemotherapy 20060701

Title: Inhibition of peptide bond formation by pleuromutilins: the structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin.

Journal: Molecular microbiology 20041201

Title: Synthesis and activity of a C-8 keto pleuromutilin derivative.

Journal: Bioorganic & medicinal chemistry letters 20030519

Title: A concise synthesis of the tricyclic skeleton of pleuromutilin and a new approach to cycloheptenes.

Journal: Organic letters 20030206

Title: A flexible strategy for the divergent modification of pleuromutilin.

Journal: Chemical communications (Cambridge, England) 20021021

Title: Treatment of resistant mycoplasma infection in immunocompromised patients with a new pleuromutilin antibiotic.

Journal: The Journal of infection 20011101

Title: Susceptibility to pleuromutilins in Brachyspira (Serpulina) hyodysenteriae.

Journal: Animal health research reviews 20010601

Title: Pleuromutilins. Part 1. The identification of novel mutilin 14-carbamates.

Journal: Bioorganic & medicinal chemistry 20010501

Title: Shang RF et al. Synthesis and biological evaluation of new pleuromutilin derivatives as antibacterial agents. Molecules. 2014 Nov 19;19(11):19050-65.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 125-65-5
Tags:125-65-5 Molecular Formula|125-65-5 MDL|125-65-5 SMILES|125-65-5 Pleuromulin
Catalog No.: AA00HHSO
125-65-5,MFCD28154633
125-65-5 | Pleuromulin
Pack Size: 5mg
Purity: 98%(HPLC)
in stock
$24.00 $17.00
Pack Size: 25mg
Purity: 98%(HPLC)
in stock
$61.00 $43.00
Pack Size: 100mg
Purity: 98%(HPLC)
in stock
$178.00 $125.00
Pack Size: 250mg
Purity: 95%
in stock
$341.00 $239.00
Pack Size: 1g
Purity: 98%(HPLC)
in stock
$556.00 $389.00
Pack Size: 5g
Purity: 98%(HPLC)
in stock
$1,223.00 $856.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00HHSO
Chemical Name: Pleuromulin
CAS Number: 125-65-5
Molecular Formula: C22H34O5
Molecular Weight: 378.5024
MDL Number: MFCD28154633
SMILES: OCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@@H](C23[C@H](C1(C)[C@H](C)CC2)C(=O)CC3)C
Properties
Complexity: 645  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 6  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 27  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 4  
Undefined Atom Stereocenter Count: 2  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.5  
Literature fold

Title: Novel pleuromutilin derivatives as antibacterial agents: synthesis, biological evaluation and molecular docking studies.

Journal: Bioorganic & medicinal chemistry letters20121001

Title: Design, synthesis, and antibacterial activity of novel pleuromutilin derivatives bearing an amino thiazolyl ring.

Journal: Archiv der Pharmazie20120801

Title: Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs).

Journal: The Journal of antimicrobial chemotherapy20120501

Title: A click chemistry approach to pleuromutilin derivatives, part 2: conjugates with acyclic nucleosides and their ribosomal binding and antibacterial activity.

Journal: Journal of medicinal chemistry20120308

Title: Pleuromutilin and its derivatives-the lead compounds for novel antibiotics.

Journal: Mini reviews in medicinal chemistry20120101

Title: Are pleuromutilin antibiotics finally fit for human use?

Journal: Annals of the New York Academy of Sciences20111201

Title: A stereoselective, Sm(II)-mediated approach to decorated cis-hydrindanes: synthetic studies on faurinone and pleuromutilin.

Journal: Organic & biomolecular chemistry20110407

Title: A concise synthesis of the molecular framework of pleuromutilin.

Journal: Chemical communications (Cambridge, England)20110207

Title: Small plasmids carrying vga(A) or vga(C) genes mediate resistance to lincosamides, pleuromutilins and streptogramin A antibiotics in methicillin-resistant Staphylococcus aureus ST398 from swine.

Journal: The Journal of antimicrobial chemotherapy20101201

Title: The pleuromutilin antibiotics: a new class for human use.

Journal: Current opinion in investigational drugs (London, England : 2000)20100201

Title: Characterization of pACK4, a mobilizable plasmid from Staphylococcus simulans biovar staphylolyticus.

Journal: Plasmid20091101

Title: Mutilins derivatives: from veterinary to human-used antibiotics.

Journal: Mini reviews in medicinal chemistry20091001

Title: Water-soluble phosphate prodrugs of pleuromutilin analogues with potent in vivo antibacterial activity against Gram-positive pathogens.

Journal: Bioorganic & medicinal chemistry letters20090915

Title: Investigating pleuromutilin-producing Clitopilus species and related basidiomycetes.

Journal: FEMS microbiology letters20090801

Title: Novel pleuromutilin derivatives with excellent antibacterial activity against Staphylococcus aureus.

Journal: Chemical biology & drug design20090601

Title: Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics in Mycobacterium smegmatis by perturbation of the drug binding pocket.

Journal: Molecular microbiology20090301

Title: A scalable synthesis of 2S-hydroxymutilin via a modified Rubottom oxidation.

Journal: The Journal of organic chemistry20090102

Title: Pleuromutilin derivatives having a purine ring. Part 3: synthesis and antibacterial activity of novel compounds possessing a piperazine ring spacer.

Journal: Bioorganic & medicinal chemistry letters20090101

Title: Pleuromutilin derivatives having a purine ring. Part 2: influence of the central spacer on the antibacterial activity against Gram-positive pathogens.

Journal: Bioorganic & medicinal chemistry letters20090101

Title: A dialdehyde cyclization cascade: an approach to pleuromutilin.

Journal: Angewandte Chemie (International ed. in English)20090101

Title: A click chemistry approach to pleuromutilin conjugates with nucleosides or acyclic nucleoside derivatives and their binding to the bacterial ribosome.

Journal: Journal of medicinal chemistry20080828

Title: Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens.

Journal: Bioorganic & medicinal chemistry letters20080615

Title: Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.

Journal: Journal of medicinal chemistry20080410

Title: Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.

Journal: Future microbiology20071201

Title: Studies on the later stage of the biosynthesis of pleuromutilin.

Journal: Bioscience, biotechnology, and biochemistry20071201

Title: Cyclopentanone ring-cleaved pleuromutilin derivatives.

Journal: European journal of medicinal chemistry20070101

Title: Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci.

Journal: Antimicrobial agents and chemotherapy20060701

Title: Inhibition of peptide bond formation by pleuromutilins: the structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin.

Journal: Molecular microbiology20041201

Title: Synthesis and activity of a C-8 keto pleuromutilin derivative.

Journal: Bioorganic & medicinal chemistry letters20030519

Title: A concise synthesis of the tricyclic skeleton of pleuromutilin and a new approach to cycloheptenes.

Journal: Organic letters20030206

Title: A flexible strategy for the divergent modification of pleuromutilin.

Journal: Chemical communications (Cambridge, England)20021021

Title: Treatment of resistant mycoplasma infection in immunocompromised patients with a new pleuromutilin antibiotic.

Journal: The Journal of infection20011101

Title: Susceptibility to pleuromutilins in Brachyspira (Serpulina) hyodysenteriae.

Journal: Animal health research reviews20010601

Title: Pleuromutilins. Part 1. The identification of novel mutilin 14-carbamates.

Journal: Bioorganic & medicinal chemistry20010501

Title: Shang RF et al. Synthesis and biological evaluation of new pleuromutilin derivatives as antibacterial agents. Molecules. 2014 Nov 19;19(11):19050-65.

Building Blocks More >
1253574-21-8
1253574-21-8
6-Chloro-n-(4-methoxybenzyl)-2-methylpyrimidin-4-amine
AA00HI3O | MFCD17084923
1260666-35-0
1260666-35-0
1-(6-Chloropyridin-3-yl)cyclobutanecarboxylic acid
AA00HIQZ | MFCD18250951
1261924-25-7
1261924-25-7
2-Hydroxy-4-(3-methoxyphenyl)pyridine
AA00HLQI | MFCD18312005
1269151-92-9
1269151-92-9
3-(Trifluoromethyl)oxolan-3-ol
AA00HRIZ | MFCD18333905
1289210-83-8
1289210-83-8
tert-Butyl 4-bromopyridine-2-carboxylate
AA00HRSS | MFCD20528685
1309668-80-1
1309668-80-1
Boc-Ala(beta-cyclobutyl)-OH dipa
AA00HS83 | MFCD19707043
1322604-60-3
1322604-60-3
3-(6-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)propanoic acid
AA00HSJS | MFCD19691808
1333255-86-9
1333255-86-9
4-Bromo-3,5,7-trichloro-2-methylquinoline
AA00HSST | MFCD20036489
133894-39-0
133894-39-0
2-Amino-5,5,7,7-tetramethyl-4,5,6,7-tetrahydro-thieno[2,3-c]pyridine-3-carbonitrile
AA00HT04 | MFCD00499047
1346542-37-7
1346542-37-7
(2-Chloropyrimidin-4-yl)methanamine hydrochloride
AA00HTCA | MFCD28386122
Submit
© 2017 AA BLOCKS, INC. All rights reserved.